Lupin shares jump 6%, hit 52-week high amid strong Q1FY25 earnings

Drug maker Lupin's shares jumped up to six per cent today hitting its 52-week high at Rs 2,025 apiece on the BSE today, August 7 in intraday trade. This is just after a day when the pharmaceutical major reported its strong first quarter results for the financial year 2025 which ended on June 30, 2024.

At 11.19 AM IST today, shares of Lupin were trading 4.9 per cent higher at Rs 2,001 on BSE.

A look at Lupin's Q1FY25 earnings

Lupin reported 77 per cent hike in its net profit to Rs 801 crore for the June quarter of FY25. This is due to robust sales across markets, the company said in an exchange filing on Tuesday, August 6.

The Mumbai-based drug maker had reported a net profit of Rs 452 crore in the April-June quarter of the last fiscal year.

The company's total revenue from operations increased to Rs 5,600 crore for the first quarter, as against Rs 4,814 crore in the June quarter of FY24.

"We have had a strong quarter on the back of the momentum we built through FY24, with performance driven by new products, key geographies, and improvement in our operating margin and profitability," Lupin Ltd Managing Director Nilesh Gupta said.

He further said, "We are on track for strong, sustainable growth and margin improvement backed by growth in sales, commercial and operating efficiencies, and a strong compliance story." The company said its sales in North America stood at Rs 2,041 crore, up 28 per cent from Rs 1,590 crore in the first quarter of last fiscal.